US3482015A
(en)
*
|
1965-02-08 |
1969-12-02 |
Merck & Co Inc |
Aerosol composition of phenylephrine tartrate and the production of such
|
US3282791A
(en)
*
|
1965-08-17 |
1966-11-01 |
Merck & Co Inc |
Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
|
US3895111A
(en)
*
|
1973-06-27 |
1975-07-15 |
American Cyanamid Co |
Asthma treatment by inhalation of micronized N,N-diethyl-4-methyl-1-piperazinecarboxamide pamoate
|
GR78151B
(en)
*
|
1982-04-05 |
1984-09-26 |
Alcon Lab Inc |
|
US4581225A
(en)
*
|
1984-04-25 |
1986-04-08 |
Eli Lilly And Company |
Sustained release intranasal formulation and method of use thereof
|
US5766573A
(en)
*
|
1988-12-06 |
1998-06-16 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
US5225183A
(en)
*
|
1988-12-06 |
1993-07-06 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
US5439670A
(en)
*
|
1989-11-28 |
1995-08-08 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
DE4003270A1
(en)
*
|
1990-02-03 |
1991-08-08 |
Boehringer Ingelheim Kg |
NEW SPEED GASES AND THEIR USE IN MEDICINE PREPARATIONS
|
US5919435A
(en)
*
|
1990-11-09 |
1999-07-06 |
Glaxo Group Limited |
Aerosol formulation containing a particulate medicament
|
US5785952A
(en)
*
|
1990-11-09 |
1998-07-28 |
Glaxo Group Limited |
Aerosol medicament formulation having a surface coating of surfactant
|
IL104068A
(en)
|
1991-12-12 |
1998-10-30 |
Glaxo Group Ltd |
Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
|
US5658549A
(en)
*
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
US5674471A
(en)
*
|
1991-12-12 |
1997-10-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and salbutamol
|
US5916540A
(en)
*
|
1994-10-24 |
1999-06-29 |
Glaxo Group Limited |
Aerosol formulations containing P134A and/or P227 and particulate medicament
|
US5736124A
(en)
*
|
1991-12-12 |
1998-04-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicament
|
US5744123A
(en)
*
|
1991-12-12 |
1998-04-28 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
ES2123576T3
(en)
|
1991-12-12 |
1999-01-16 |
Glaxo Group Ltd |
MEDICINES.
|
DE69205177T2
(en)
*
|
1991-12-12 |
1996-03-21 |
Glaxo Group Ltd., Greenford, Middlesex |
Pharmaceutical aerosol formulation.
|
US5683676A
(en)
*
|
1991-12-12 |
1997-11-04 |
Glaxo Group Limited |
Canister containing aerosol formulations containing P134a and particulate medicaments
|
US7101534B1
(en)
|
1991-12-18 |
2006-09-05 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
ES2159678T3
(en)
*
|
1991-12-18 |
2001-10-16 |
Minnesota Mining & Mfg |
AEROSOL FORMULATIONS IN SUSPENSION.
|
US7105152B1
(en)
|
1991-12-18 |
2006-09-12 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
US5603918A
(en)
*
|
1995-06-09 |
1997-02-18 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aerosol composition of a salt of ipratropium and a salt of albuterol
|
US8022095B2
(en)
*
|
1996-08-16 |
2011-09-20 |
Pozen, Inc. |
Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
|
US7899511B2
(en)
|
2004-07-13 |
2011-03-01 |
Dexcom, Inc. |
Low oxygen in vivo analyte sensor
|
US9155496B2
(en)
|
1997-03-04 |
2015-10-13 |
Dexcom, Inc. |
Low oxygen in vivo analyte sensor
|
US7657297B2
(en)
|
2004-05-03 |
2010-02-02 |
Dexcom, Inc. |
Implantable analyte sensor
|
US8465425B2
(en)
|
1998-04-30 |
2013-06-18 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US6949816B2
(en)
|
2003-04-21 |
2005-09-27 |
Motorola, Inc. |
Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
|
US6175752B1
(en)
|
1998-04-30 |
2001-01-16 |
Therasense, Inc. |
Analyte monitoring device and methods of use
|
US8346337B2
(en)
|
1998-04-30 |
2013-01-01 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8480580B2
(en)
|
1998-04-30 |
2013-07-09 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US9066695B2
(en)
|
1998-04-30 |
2015-06-30 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8974386B2
(en)
|
1998-04-30 |
2015-03-10 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8688188B2
(en)
|
1998-04-30 |
2014-04-01 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US20080076997A1
(en)
*
|
1998-04-30 |
2008-03-27 |
Abbott Diabetes Care, Inc. |
Analyte monitoring device and methods of use
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
JP2003509359A
(en)
*
|
1999-09-11 |
2003-03-11 |
グラクソ グループ リミテッド |
Pharmaceutical formulation of fluticasone propionate
|
US6458387B1
(en)
*
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
US20050048001A1
(en)
*
|
1999-11-23 |
2005-03-03 |
Cripps Alan Leslie |
Pharmaceutical formulations of salmeterol
|
EP1248597B1
(en)
*
|
1999-12-24 |
2005-03-30 |
Glaxo Group Limited |
Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
|
DE10043509A1
(en)
*
|
2000-09-01 |
2002-03-14 |
Asta Medica Ag |
Solid peptide preparations for inhalation and their manufacture
|
US7374782B2
(en)
|
2000-10-27 |
2008-05-20 |
Baxter International Inc. |
Production of microspheres
|
US6560471B1
(en)
|
2001-01-02 |
2003-05-06 |
Therasense, Inc. |
Analyte monitoring device and methods of use
|
EP1397068A2
(en)
|
2001-04-02 |
2004-03-17 |
Therasense, Inc. |
Blood glucose tracking apparatus and methods
|
ATE415155T1
(en)
*
|
2001-05-24 |
2008-12-15 |
Alexza Pharmaceuticals Inc |
ADMINISTRATION OF ALPRAZOLAM, ESTAZOLAM, MIDAZOLAM, OR TRIAZOLAM BY INHALATION
|
US7458374B2
(en)
|
2002-05-13 |
2008-12-02 |
Alexza Pharmaceuticals, Inc. |
Method and apparatus for vaporizing a compound
|
CA2446904A1
(en)
|
2001-05-24 |
2003-04-03 |
Alexza Molecular Delivery Corporation |
Delivery of drug esters through an inhalation route
|
WO2002094242A1
(en)
*
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of rizatriptan or zolmitriptan through an inhalation route
|
US7645442B2
(en)
|
2001-05-24 |
2010-01-12 |
Alexza Pharmaceuticals, Inc. |
Rapid-heating drug delivery article and method of use
|
DE60227659D1
(en)
*
|
2001-05-24 |
2008-08-28 |
Alexza Pharmaceuticals Inc |
ADMINISTRATION OF ANTIHISTAMINICA BY INHALATION
|
US7585493B2
(en)
|
2001-05-24 |
2009-09-08 |
Alexza Pharmaceuticals, Inc. |
Thin-film drug delivery article and method of use
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
US7090830B2
(en)
|
2001-05-24 |
2006-08-15 |
Alexza Pharmaceuticals, Inc. |
Drug condensation aerosols and kits
|
US20030051728A1
(en)
|
2001-06-05 |
2003-03-20 |
Lloyd Peter M. |
Method and device for delivering a physiologically active compound
|
US7498019B2
(en)
|
2001-05-24 |
2009-03-03 |
Alexza Pharmaceuticals, Inc. |
Delivery of compounds for the treatment of headache through an inhalation route
|
US20030035774A1
(en)
*
|
2001-07-18 |
2003-02-20 |
Adjei Akwete L. |
Salt/ion pair medicinal aerosol formulation
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
EP1944016A1
(en)
|
2001-08-16 |
2008-07-16 |
Baxter International Inc. |
Propellant-based microparticle formulatons
|
EP1418890B1
(en)
*
|
2001-08-16 |
2008-05-14 |
Baxter International Inc. |
Propellant-based microparticle formulations
|
WO2003041693A1
(en)
*
|
2001-11-09 |
2003-05-22 |
Alexza Molecular Delivery Corporation |
Delivery of diazepam through an inhalation route
|
US8010174B2
(en)
|
2003-08-22 |
2011-08-30 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US10022078B2
(en)
|
2004-07-13 |
2018-07-17 |
Dexcom, Inc. |
Analyte sensor
|
US8260393B2
(en)
|
2003-07-25 |
2012-09-04 |
Dexcom, Inc. |
Systems and methods for replacing signal data artifacts in a glucose sensor data stream
|
US9282925B2
(en)
|
2002-02-12 |
2016-03-15 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US9247901B2
(en)
|
2003-08-22 |
2016-02-02 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
AU2003230691A1
(en)
*
|
2002-03-20 |
2003-10-08 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
US7582284B2
(en)
|
2002-04-17 |
2009-09-01 |
Nektar Therapeutics |
Particulate materials
|
WO2003094900A1
(en)
|
2002-05-13 |
2003-11-20 |
Alexza Molecular Delivery Corporation |
Delivery of drug amines through an inhalation route
|
EP1567164B1
(en)
|
2002-11-26 |
2009-01-14 |
Alexza Pharmaceuticals, Inc. |
Use of loxapine for the manufacture of a medicament for the treatment of pain
|
US20040105818A1
(en)
|
2002-11-26 |
2004-06-03 |
Alexza Molecular Delivery Corporation |
Diuretic aerosols and methods of making and using them
|
US7550133B2
(en)
|
2002-11-26 |
2009-06-23 |
Alexza Pharmaceuticals, Inc. |
Respiratory drug condensation aerosols and methods of making and using them
|
US7913688B2
(en)
|
2002-11-27 |
2011-03-29 |
Alexza Pharmaceuticals, Inc. |
Inhalation device for producing a drug aerosol
|
ES2370395T3
(en)
|
2003-05-21 |
2011-12-15 |
Alexza Pharmaceuticals, Inc. |
USE OF A SOLID FUEL LAYER, MANUFACTURING PROCEDURE AND CORRESPONDING HEATING UNIT.
|
US8423113B2
(en)
|
2003-07-25 |
2013-04-16 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US7761130B2
(en)
|
2003-07-25 |
2010-07-20 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
US8282549B2
(en)
|
2003-12-09 |
2012-10-09 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
US8275437B2
(en)
|
2003-08-01 |
2012-09-25 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US7591801B2
(en)
|
2004-02-26 |
2009-09-22 |
Dexcom, Inc. |
Integrated delivery device for continuous glucose sensor
|
US9135402B2
(en)
|
2007-12-17 |
2015-09-15 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US20190357827A1
(en)
|
2003-08-01 |
2019-11-28 |
Dexcom, Inc. |
Analyte sensor
|
US7276029B2
(en)
|
2003-08-01 |
2007-10-02 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US7774145B2
(en)
|
2003-08-01 |
2010-08-10 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8369919B2
(en)
|
2003-08-01 |
2013-02-05 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US8160669B2
(en)
|
2003-08-01 |
2012-04-17 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8761856B2
(en)
|
2003-08-01 |
2014-06-24 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8332008B2
(en)
|
2003-08-01 |
2012-12-11 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8845536B2
(en)
|
2003-08-01 |
2014-09-30 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US20100168657A1
(en)
|
2003-08-01 |
2010-07-01 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8886273B2
(en)
|
2003-08-01 |
2014-11-11 |
Dexcom, Inc. |
Analyte sensor
|
US20140121989A1
(en)
|
2003-08-22 |
2014-05-01 |
Dexcom, Inc. |
Systems and methods for processing analyte sensor data
|
US7920906B2
(en)
|
2005-03-10 |
2011-04-05 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US8233959B2
(en)
|
2003-08-22 |
2012-07-31 |
Dexcom, Inc. |
Systems and methods for processing analyte sensor data
|
US9247900B2
(en)
|
2004-07-13 |
2016-02-02 |
Dexcom, Inc. |
Analyte sensor
|
WO2005051170A2
(en)
|
2003-11-19 |
2005-06-09 |
Dexcom, Inc. |
Integrated receiver for continuous analyte sensor
|
ATE480761T1
(en)
|
2003-12-05 |
2010-09-15 |
Dexcom Inc |
CALIBRATION METHODS FOR A CONTINUOUSLY WORKING ANALYTICAL SENSOR
|
US11633133B2
(en)
|
2003-12-05 |
2023-04-25 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
US8423114B2
(en)
|
2006-10-04 |
2013-04-16 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
US8774886B2
(en)
|
2006-10-04 |
2014-07-08 |
Dexcom, Inc. |
Analyte sensor
|
US8364231B2
(en)
|
2006-10-04 |
2013-01-29 |
Dexcom, Inc. |
Analyte sensor
|
US8287453B2
(en)
|
2003-12-05 |
2012-10-16 |
Dexcom, Inc. |
Analyte sensor
|
US20070020299A1
(en)
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
|
EP1729724A4
(en)
*
|
2003-12-31 |
2008-07-23 |
Cydex Inc |
Inhalent formulation containing sulfoalkyl ether gamma-cyclodextryn and corticosteroid
|
US20070020196A1
(en)
*
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
|
US7637868B2
(en)
|
2004-01-12 |
2009-12-29 |
Dexcom, Inc. |
Composite material for implantable device
|
US8808228B2
(en)
|
2004-02-26 |
2014-08-19 |
Dexcom, Inc. |
Integrated medicament delivery device for use with continuous analyte sensor
|
US8792955B2
(en)
|
2004-05-03 |
2014-07-29 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
US8452368B2
(en)
|
2004-07-13 |
2013-05-28 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US20060016700A1
(en)
|
2004-07-13 |
2006-01-26 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8565848B2
(en)
|
2004-07-13 |
2013-10-22 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8886272B2
(en)
|
2004-07-13 |
2014-11-11 |
Dexcom, Inc. |
Analyte sensor
|
US9044199B2
(en)
|
2004-07-13 |
2015-06-02 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US7783333B2
(en)
|
2004-07-13 |
2010-08-24 |
Dexcom, Inc. |
Transcutaneous medical device with variable stiffness
|
CA2576961A1
(en)
|
2004-08-12 |
2006-03-02 |
Alexza Pharmaceuticals, Inc. |
Aerosol drug delivery device incorporating percussively activated heat packages
|
US20090076360A1
(en)
|
2007-09-13 |
2009-03-19 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8133178B2
(en)
|
2006-02-22 |
2012-03-13 |
Dexcom, Inc. |
Analyte sensor
|
US8367734B1
(en)
|
2005-08-11 |
2013-02-05 |
Amphastar Pharmaceuticals Inc. |
Stable epinephrine suspension formulation with high inhalation delivery efficiency
|
US20070197486A1
(en)
*
|
2005-12-20 |
2007-08-23 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids
|
US20070160542A1
(en)
*
|
2005-12-20 |
2007-07-12 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
|
US20070197487A1
(en)
*
|
2005-12-20 |
2007-08-23 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids having an increased lung deposition
|
US20070178050A1
(en)
*
|
2005-12-20 |
2007-08-02 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids having an increased lung depositon
|
US20070178049A1
(en)
*
|
2005-12-20 |
2007-08-02 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
|
US20070185066A1
(en)
*
|
2005-12-20 |
2007-08-09 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids
|
US20070249572A1
(en)
*
|
2005-12-20 |
2007-10-25 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids
|
US9757061B2
(en)
|
2006-01-17 |
2017-09-12 |
Dexcom, Inc. |
Low oxygen in vivo analyte sensor
|
US20080071157A1
(en)
|
2006-06-07 |
2008-03-20 |
Abbott Diabetes Care, Inc. |
Analyte monitoring system and method
|
US20070286814A1
(en)
*
|
2006-06-12 |
2007-12-13 |
Medispray Laboratories Pvt. Ltd. |
Stable aerosol pharmaceutical formulations
|
ES2691033T3
(en)
|
2007-02-11 |
2018-11-23 |
Map Pharmaceuticals Inc. |
Therapeutic administration method of DHE to activate rapid migraine relief while minimizing the profile of side effects
|
WO2008112661A2
(en)
|
2007-03-09 |
2008-09-18 |
Alexza Pharmaceuticals, Inc. |
Heating unit for use in a drug delivery device
|
US20080306444A1
(en)
|
2007-06-08 |
2008-12-11 |
Dexcom, Inc. |
Integrated medicament delivery device for use with continuous analyte sensor
|
EP4159114B1
(en)
|
2007-10-09 |
2024-04-10 |
DexCom, Inc. |
Integrated insulin delivery system with continuous glucose sensor
|
US8597616B2
(en)
*
|
2007-10-22 |
2013-12-03 |
Board Of Regents Of The University Of Texas System |
Dry powder drug delivery formulations, methods of use, and devices therefore
|
US8417312B2
(en)
|
2007-10-25 |
2013-04-09 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US8040246B2
(en)
*
|
2007-12-04 |
2011-10-18 |
Avaya Inc. |
Systems and methods for facilitating a first response mission at an incident scene
|
US9839395B2
(en)
|
2007-12-17 |
2017-12-12 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
EP2252196A4
(en)
|
2008-02-21 |
2013-05-15 |
Dexcom Inc |
Systems and methods for processing, transmitting and displaying sensor data
|
US8396528B2
(en)
|
2008-03-25 |
2013-03-12 |
Dexcom, Inc. |
Analyte sensor
|
US8560039B2
(en)
|
2008-09-19 |
2013-10-15 |
Dexcom, Inc. |
Particle-containing membrane and particulate electrode for analyte sensors
|
EP2410910A4
(en)
|
2009-03-27 |
2014-10-15 |
Dexcom Inc |
Methods and systems for promoting glucose management
|
ES2847578T3
(en)
|
2011-04-15 |
2021-08-03 |
Dexcom Inc |
Advanced analyte sensor calibration and error detection
|
CN209606445U
(en)
|
2017-10-24 |
2019-11-08 |
德克斯康公司 |
Pre-connection analyte sensor
|
US11331022B2
(en)
|
2017-10-24 |
2022-05-17 |
Dexcom, Inc. |
Pre-connected analyte sensors
|